Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Psychiatric Research|August 20, 2020
Staging of depressive disorders: Relevance of resistance to treatment and residual symptomsBlanca Reneses, Luis Aguera-Ortiz, Julia Sevilla-Llewellyn-Jones, et al.
Psychiatry Research|December 4, 2014
Is it possible to combine different psychotic symptom scales in bipolar disorder?Helena Fernandez-Garcimartin, Alexandra Bagney, Marta Moreno-Ortega, et al.
Psychopathology|November 14, 2012
Negative symptoms and executive function in schizophrenia: does their relationship change with illness duration?Alexandra Bagney, Roberto Rodriguez-Jimenez, Isabel Martinez-Gras, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 22, 2006
(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish populationIsabel Martínez-Gras, Janet Hoenicka, Guillermo Ponce, et al.
Schizophrenia Research|October 27, 2009
Executive function in schizophrenia: influence of substance use disorder historyRoberto Rodriguez-Jimenez, Alexandra Bagney, Isabel Martinez-Gras, et al.
Medical Hypotheses|May 1, 2007
Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesisKenneth Blum, Thomas J H Chen, Brian Meshkin, et al.
Advances in Therapy|June 15, 2007
Gene \Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndromeThomas J H Chen, Kenneth Blum, Roger L Waite, et al.
Behavioural Brain Research|August 29, 2009
Differential dorsolateral prefrontal cortex activation during a verbal n-back task according to sensory modalityRoberto Rodriguez-Jimenez, Cesar Avila, Cristina Garcia-Navarro, et al.
Schizophrenia Research|December 4, 2012
Cognition and the five-factor model of the positive and negative syndrome scale in schizophreniaRoberto Rodriguez-Jimenez, Alexandra Bagney, Laura Mezquita, et al.
Advances in Therapy|September 11, 2008
LG839: anti-obesity effects and polymorphic gene correlates of reward deficiency syndromeKenneth Blum, Amanda L C Chen, Thomas J H Chen, et al.
Pageof 4